Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novo Nordisk describes the first nonpeptide competitive glucagon antagonist

Sep. 1, 1998

Androsorb to enter second part of hormone replacement therapy trial

Sep. 1, 1998

New ACAT inhibitors synthesized at Sumitomo

Aug. 31, 1998

Columbia Laboratories develops hormone replacement tablet for men

Aug. 31, 1998

Unimed's Androgel shows promising phase II results

Aug. 31, 1998

Another beta3-adrenergic agent added to the BMS pipeline

Aug. 28, 1998

Ergo Science submits amendment to Ergoset NDA

Aug. 28, 1998

Bristol-Myers Squibb program on beta3-adrenoceptor agonists outlined at ACS

Aug. 27, 1998

Fuji Chemical patents new treatment for kidney disease in diabetic patients

Aug. 27, 1998

Selective alphav/beta3 integrin receptor antagonists from DuPont Pharmaceuticals

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...